Learning Objectives:

1.  Describe patterns in the clinical features and disease trajectories of patients in the DodoNA migraine cohort.

2.  Describe how a genetic risk score is calculated and its potential clinical utility.

3.  Discuss the interpretation of a specific migraine genetic risk score in the context of clinical features seen in the DodoNA migraine cohort.

Session date: 
08/17/2021 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Bruce Chase, PhD